Drug Cos. Question When Reissued Patent Is Actually Issued

By Andrew Karpan · October 25, 2023, 6:28 PM EDT

Generic drugmakers trying to break Merck's hold on a blockbuster anesthesia-reversing drug are telling the Federal Circuit that a New Jersey federal judge's idea of when a reissued patent is actually...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Brief

Case Information

Case Title

Merck Sharp & Dohme B.V. v. Aurobindo Pharma USA, Inc.

Case Number

Court

Appellate - Federal Circuit

Nature of Suit

835 Patent - (ANDA) (Fed. Qst.)

Date Filed

August 09, 2023

Recent Articles By Andrew

January 08, 2025
Patent Board Knocks Out Most Of Apple Patent
January 08, 2025
Telligen's TM Suit Against IT Co. Can Move Forward
January 06, 2025
Labcorp Loses Appeal Of Gene-Testing Patent In $372M Case
December 04, 2024
Withers IP Partners Hop To Sullivan & Worcester
December 02, 2024
Judge Isn't Seeing 'Good Faith' Compliance In Probiotic Feud
November 22, 2024
Wellness Software Co. Not Immune From IP Suit, Judge Says
November 19, 2024
Judge Rejects Infosys' Bid To Seal NDAs In Trade Secrets Row
November 18, 2024
Melinta Obtains Ban On Generic Antibiotic Injections In IP Row
November 12, 2024
GOP Reps. Propose Another Bill On TRIPS Waivers
October 23, 2024
Court Denies Fees In 'Objectively Specious' Trade Secrets Suit